Markets.com Logo
markets.com

IORYX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

IORYX.US represents the shares of IORYX AS, a Norwegian biotechnology company listed on the OTCQX Best Market in the United States. IORYX AS is focused on developing and commercializing innovative drug delivery technologies to improve the efficacy and safety of existing and new pharmaceuticals. The company's proprietary technology platform is designed to enhance drug bioavailability and targeting, potentially leading to better patient outcomes across various therapeutic areas. Investors should be aware of the risks associated with investing in small-cap biotechnology companies, including regulatory hurdles, clinical trial failures, and competition.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Factor Name: Net Asset Value (NAV)

Explanation: IORYX.US, likely a mutual fund, is primarily priced based on its NAV, which is the total value of its assets (stocks, bonds, etc.) minus liabilities, divided by the number of outstanding shares. Changes in the underlying asset values directly impact the NAV and thus the fund's price. Factor Name: Market Sentiment

Explanation: Overall investor confidence or fear in the markets, particularly towards the sectors or asset classes in which the fund invests, can influence demand for IORYX.US shares, potentially causing the price to deviate slightly from its NAV, especially in times of market volatility. Factor Name: Supply and Demand

Explanation: While usually closely tied to NAV, increased demand for IORYX.US shares can drive the price up, while increased selling pressure can push it down. This is less pronounced than for individual stocks, but still a contributing factor.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com